Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 29, 2009


Todd Johnson has been named senior vice president of marketing and operations at Accelrys.

Johnson was most recently the firm's interim president and CEO after the resignation of Mark Emkjer in January. He held that post through June 15, when the company tapped Max Carnecchia as its new CEO.

According to an SEC filing, Johnson will be employed on a part-time basis with an annual base salary of $111,000 and is eligible for a bonus.

Johnson was previously senior vice president of strategy and corporate development at MDS Pharma Services. He has also held positions as a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company.

Prior to that he was CEO of Tangerine Technologies and was a cancer researcher at the Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.